Document |
Document Title |
WO/2011/046267A1 |
The present invention relates to a silver/polydiguanide complex and derivatives thereof including silver and polydiguanide having at least two biguanide moieties, wherein the silver is stabilized in an oxidation state of an integer of 0 ...
|
WO/2011/047245A1 |
Monomelic metal complexes having desirable luminescence properties are provided. In one embodiment, a monomeric metal compound is represented by the formula (ArN)M(L)x, where ArN is an arylamido ligand, and M may be any metal capable of ...
|
WO/2010/151879A9 |
The present invention describes Photolabile Compounds methods for use of the compounds. The Photolabile Compounds have a photoreleasable ligand, which can be biologically active, and which is photoreleased from the compound upon exposure...
|
WO/2011/033023A1 |
The present invention provides an organic electronic device, comprising a substrate, a first electrode, arranged on the substrate, at least a first functional organic layer arranged on the first electrode and a second electrode arranged ...
|
WO/2011/032269A1 |
The present invention provides a modular approach to preparing a large array of substituted cyclometalated compounds which behave as dyes having intense absorbance bands in the visible spectrum The compounds include at least one terpyrid...
|
WO/2011/028594A2 |
The present invention is a glutamine analogue which enters the mitochondrion and is subsequently exposed to ionizing radiation. When exposed to ionizing radiation, the present invention damages mitochondrial (as well as other) substructu...
|
WO/2011/026886A1 |
The invention relates to dinuclear carbene complexes containing Ag, Au, and/or Cu as metal cations, and a method for the production of said dinuclear carbene complexes by bringing compounds that contain the corresponding metal cation in ...
|
WO/2011/008132A1 |
Claimed are a compound of the general formula (I) and pharmaceutically acceptable salts thereof, where M signifies metal atoms selected independently from the group comprising Pd, Fe, Mn, Co, Ni, Cu, Zn and Mo; R1 and R2, independently o...
|
WO/2011/006353A1 |
Embodiments of the invention are directed to luminescent gold(III) compounds contains a bidentate ligand with at least one strong σ-donating group, a method of preparation of these compounds and the use of these compounds in organic lig...
|
WO/2011/008501A2 |
A group of compounds defined by the general formula (I) can be used to anionically initiate polymerization of unsaturated monomers. In the formula, M is an alkali metal atom, R1 is an aryl group having at least one OR2 substituent group ...
|
WO/2011/002920A2 |
Disclosed are lithium-containing compounds and methods of utilizing the same. The disclosed compounds may be used to deposit alkali metal-containing layers using vapor deposition methods such as chemical vapor deposition or atomic layer ...
|
WO/2010/149748A1 |
The invention relates to copper(I) complexes of the formula (A) with X = Cl, Br or I (independently of one another) N*⌒E = a bidentate ligand, with E = phosphanyl/arsenyl radical of the form R2E (where R = alkyl, aryl, alkoxy, phenoxy ...
|
WO/2010/132871A1 |
A precursor for the deposition of a thin film by atomic layer deposition is provided. The compound has the formula MxLy where M is a metal and L is an amidrazone-derived ligand or an amidate-derived ligand. A process of forming a thin fi...
|
WO/2010/123131A1 |
Disclosed is a metal complex which contains a nitrogen-containing aromatic ligand having a dendritic molecular chain, and a copper (I) ion or a silver (I) ion. For example, a metal complex represented by composition formula (8) has excel...
|
WO/2010/118661A1 |
The method for preparing metal compounds of 8-hydroxyquinoline or its derivatives thereof with the formula of Mqnq'm is provided. Wherein M = Al or Li, n = 1-3, m = 0-2, q = 8-hydroxyquinoline or its derivatives, and q' = ligand differen...
|
WO2010110574A2 |
The present invention relates to a bile salt adjuvant for animals for improving fat utilization efficiency in the bodies of the animals, and to animal feed comprising same. More particularly, the present invention relates to a bile salt ...
|
WO/2010/105691A1 |
The invention concerns Au(III) complexes of the type [AuIIIX2(Pdtc)] (X = halogen, pseudo-halogen; pdtc = peptide-/esterified peptidedithiocarbamato) which are able to both maintain the antitumor properties and the lack of nephrotoxic si...
|
WO/2010/101204A1 |
A binaphthyldisulfonic acid compound represented by formula (1a) or (1b). (In the formulae, R1 is a hydrogen atom, an alkyl, or a metal ion (e.g., Li, Na, K, Mg, or Ca); R2 is a halogen atom, a heavy hydrogen atom, a trialkylsilyl, dihyd...
|
WO/2010/090178A1 |
A donor-acceptor compound represented by general formula (1) [wherein M is Na2, Mg, Al, Ti=O, V=O, Cr, Mn, Fe, Co, Ni, Cu, Pt, Au, or the like, or alternatively is free from metal; A is a straight-chain alkoxy group, a branched alkoxy gr...
|
WO/2010/090413A2 |
The present invention relates to a 3D metal-organic framework having a wide surface area and a large pore volume, and more particularly, to the 3D metal-organic framework expressed in chemical formula 3, or to a solvate thereof. The meta...
|
WO/2010/086089A1 |
The present invention relates to metal complexes and electronic devices, in particular organic electroluminescent devices comprising said metal complexes.
|
WO/2010/082503A1 |
A novel gold complex which has potent antitumor activity and is effective when administered in a smaller amount, and a medicinal composition containing the complex. The gold complex includes, as a ligand, (R,R,R)-cis,cis-spiro[4,4]nonane...
|
WO/2010/082924A1 |
Cross-linkable copper complexes comprising a copper phthalocyanine core and one or more cross- linkable functionalities linked to the phthalocyanine core. The copper complex may have a spacer group with the one or more cross-linkable fun...
|
WO/2010/076969A2 |
Disclosed are novel copper phthalocyanine compounds with low absorption efficiency in the visible light domain and high absorption efficiency in the near-infrared light domain, and a near-infrared absorption filter using the same. The ne...
|
WO/2010/073714A1 |
A process for producing an organolithium compound which comprises a step in which an aromatic compound or a halogenated unsaturated aliphatic compound is reacted with a lithiating agent at a temperature of -40ºC to 40ºC in the presence...
|
WO/2010/071097A1 |
A method for producing a lithium difluorobis(oxalato)phosphate solution which comprises mixing lithium hexafluorophosphate with oxalic acid in a nonaqueous solvent in such a manner that the molar ratio of lithium hexafluorophosphate to o...
|
WO/2010/066010A1 |
The present invention relates to a method of making asymmetrical bis(thiosemicarbazones), compounds useful as synthetic intermediates in the method, new bis(thiosemicarbazones) that can be readily accessed by use of the method and method...
|
WO/2010/062221A1 |
The invention relates to new substituted 2-(5-hydroxy-2-methyl-1n-indole-3-il) acetic acids, new antiviral active agents, pharmaceutical compositions, antiviral medicinal agents and a method for preventing and treating viral diseases, in...
|
WO/2010/048936A2 |
The present invention relates to double complex salts in optoelectronic components, such as an organic diode, an organic transistor or an organic laser, particularly of an organic solar cell (OSC, OPV), and particularly of oligomers form...
|
WO/2010/043218A2 |
The invention relates to a ligand of formula (I), where (CH-R1) and (CH-R1’) are substituted or non-substituted methylene bridges; the individual R1 and R1’, and R3 and R3’, are each selected independently of each other from hydrog...
|
WO/2010/035990A2 |
The present invention relates to a polymer compound that enables the maximization of compatibility between a polymer and a reinforcement agent and a novel initiator required for the polymerization thereof, and particularly to a new polym...
|
WO/2010/028780A2 |
The invention relates to porphyrins, porphyrazines and phthalocyanines carrying a guanidine substituent. These compounds are obtained by treating a porphyrin, porphyrazine or phthalocyanine, respectively, carrying an amino substituent wi...
|
WO/2010/030017A1 |
A method for producing an optically active cyclopropane carboxylic acid ester compound represented by formula (4), said method being characterized in that a diazoacetic acid ester represented by formula (2) and a compound represented by ...
|
WO/2010/028105A2 |
Processes for the preparation of amorphous pemetrexed disodium, and removal of residual solvents from amorphous pemetrexed disodium.
|
WO/2010/021345A1 |
Disclosed is a metal complex that can be used as a gas absorption material with superior gas absorbing properties, a gas storage material with a high storage capacity, and a gas separation material with superior gas separation performanc...
|
WO/2010/020352A1 |
The invention provides compounds having utility inter alia as electron transport materials in optical light emitting diodes (OLEDs) and of the formula (I), (Il) or (III). Embodiments of the compounds when incorporated as electron transpo...
|
WO/2010/018782A1 |
Copper-containing nanoparticles having excellent oxidation resistance; and a process for producing copper-containing nanoparticles, which is characterized by heat-treating an organic copper compound at a temperature equal to or higher th...
|
WO/2010/012715A1 |
The present invention relates to a porous metal-organic structural material containing at least one first organic compound and ions of at least one metal, wherein the structure of the structural material is at least partially formed in t...
|
WO/2010/011922A2 |
The invention relates to novel crystalline salts of 5-[(lZ,2E)-2-methyl-3- phenyIpropenylidene]-4-oxo-2-thioxo-3-thiazolidineaeetic acid. The preparation and characterization of the crystalline salts according to various embodiments of t...
|
WO/2010/008065A1 |
Disclosed is a method for manufacturing substituted ethynyl gold-nitrogen containing heterocyclic carbene complexes represented by general formula (3) that is characterized in that substituted ethylene represented by general formula (1) ...
|
WO/2009/153272A2 |
The invention relates to a method for iodinating aromatic and/or heteroaromatic compounds, characterized in that aromatic compounds are reacted with an iodine source in the presence of at least one base and at least one catalyst containi...
|
WO/2009/149381A2 |
The disclosure provides metal organic frameworks useful for sensing, gas sorption, microelectronics and switches.
|
WO/2009/131536A1 |
The invention is related to a molecular assembly comprising a ligand, a linker and a detectable entity,wherein the ligand is covalently bound to the linker, and the linker is a chelating agent forming a coordination complex with the dete...
|
WO/2009/129350A2 |
The present invention is directed to a process for the preparation of the saponification products of lactones, preferably three- to eight-membered lactones. The present invention is also directed to a process for the preparation of compo...
|
WO/2009/127559A1 |
There is described a sodium salt of the general formula (I) Na-CH2-CR1R2R3 (I) where R1 denotes H or CH3;R2 denotes C1-5-alkyl and R3 denotes C2‑6‑alkyl.
|
WO/2009/123016A1 |
Disclosed is a copper phosphonate compound that can exhibit broad and excellent light absorption in a near infrared region and, at the same time, when mixed with a resin, can realize excellent transparency to visible light. The copper ph...
|
WO/2009/121989A1 |
The invention relates to a highly enantioselective method catalysed by small quantities of a chiral complex of cationic silver, which can be used to generate polysubstituted pyrrolidines which give rise to derivatives of substituted prol...
|
WO/2009/113646A1 |
Disclosed are substituted ethynyl gold-cyclic-(alkyl)(amino)carbene complexes and organic electroluminescence elements represented by general formula (1) In the formula, L represents a cyclic(alkyl)(amino)carbene ligand; X represents an ...
|
WO/2009/110499A1 |
A method for water purification which comprises bringing a scavenger containing both a compound represented by general formula (I) and metal ions capable of square planar coordination or octahedral coordination into contact with water co...
|
WO/2009/103807A1 |
The present invention relates to copper organocomplexes and pharmaceutical compositions comprised thereof. They can be used for the treatment of illnesses caused by hyperproliferative cells, and they also protect healthy tissue from ioni...
|